Kantonsspital Winterthur
Winterthur, Canton of Zurich, 8400, Switzerland
Location status: Recruiting
NCT Number: NCT06776731
Chronic obstructive pulmonary disease (COPD) is a global burden. Treatment options have improved in recent years, pulmonary rehabilitation plays a key role. Oxygen therapy is recommended in patients with a low saturation at rest, but no clear guidance is given for patients who desaturate during exercise. The effect of ambulatory oxygen during exercise is not yet completely understood, especially in those patients with exercise-induced desaturation.
Aim: Evaluate the effect of supplemental oxygen therapy during a 3-months long ambulatory pulmonary rehabilitation program on exercise endurance. Patients will either receive supplemental oxygen therapy or room air during exercise training.
Methods: A total of 32 patients with a confirmed diagnosis of COPD undergoing pulmonary rehabilitation will be included (male and female : aged ≥ 18 years; stable condition > 3 weeks (e.g. no exacerbations); resting oxygen saturation (SpO2) ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/ or below 90% during a 6-minute walking test). 3-months comprehensive PR for both intervention and control group including: education and awareness, instruction on inhalation therapies, smoking cessation counselling, respiratory and skeletal muscle training in groups, guided walks / cycle ergometer training. The intervention group will be trained using SSOT and the control group will receive sham air (ambient air). Patients and assessors will be blinded. Between group difference in cycling constant work rate exercise test (CWRET) time from baseline to 3 months SSOT (5l/min) vs ambient air will be the primary outcome of this study.
Data will be summarized by means (SD) and medians (quartiles) for normal and non-normal distributions. Effects of treatment will be evaluated by mean differences with 95% confidence intervals, T-tests or Wilcoxon matched pair tests as appropriate. A p-value threshold of <0.05 or a confidence interval not including zero will be considered as statistically significant. Analyses will be performed according to the intention to treat principle.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Winterthur, Canton of Zurich, 8400, Switzerland
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard supplemental Oxygen therapy (5l/min) will be applied with an oxygen concentrator via nasal cannula during endurance training.
Room air (5l/min) will be applied with an oxygen concentrator via nasal cannula during endurance training.
Time frame: 3 months
Constant Work Rate Exercise Test Endurance time measured with Constant Work Rate Exercise Test (CWRET) (75% of the maximal work rate from the maximal ramp exercise test)
Time frame: 3 months
6 minute walk distance (6MWD), SpO2 and heart rate at the end of the 6 minute walk test (6MWT) from baseline to 3 months at SSOT vs ambient air
Time frame: 3 months
SpO2 by finger pulse oximetry, brain and muscle tissue oxygenation by NIRS at rest and end-exercise CWRET from baseline to 3 months at SSOT vs ambient air
Time frame: 3 months
Heart rate at rest and end-exercise CWRET from baseline to 3 months at SSOT vs ambient air
Time frame: 3 months
Borg scale (Dyspnoea and fatigue) at rest and end-exercise CWRET from baseline to 3 months at SSOT vs ambient air. Measure of perceived exertion from 1-10, ranges from 1 (very light exertion) to 10 (maximum exertion).
Time frame: 6 months
Constant Work Rate Exercise Test Endurance time measured with Constant Work Rate Exercise Test (CWRET) (75% of the maximal work rate from the maximal ramp exercise test)
Contact information is provided by the study sponsor or research team.
Spencer Rezek
CONTACT
Stéphanie Saxer, PHD
CONTACT
Eastern Switzerland University of Applied Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06376994
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Birmingham, Alabama, United States
View Trial DetailsNCT07288554
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Hefei, Anhui, China
View Trial DetailsNCT06946953
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Qionghai, Hainan, China
View Trial DetailsNCT06653413
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Guangzhou, Guangdong, China
View Trial Details